Previous Page  19 / 20 Next Page
Information
Show Menu
Previous Page 19 / 20 Next Page
Page Background

Volume 4, Issue 3 (Suppl)

Health Care: Current Reviews

ISSN: 2375-4273 HCCR, an open access journal

Page 50

Notes:

Primary Care Congress 2016

September 19-20, 2016

conferenceseries

.com

September 19-20, 2016 Phoenix, USA

2

nd

Annual Congress and Medicare Expo on

Primary Care & General Pediatrics

Confluence of biological inspiration and chemical intuition in search of novel drugs against malaria

Dinkar Sahal

International Centre for Genetic Engineering and Biotechnology, India

T

he parasite that causes malaria has been tormenting mankind for a long time and the image of a child dying of malaria every

minute continues to haunt us even today. Our handling of malaria for the last hundred years has taught us that the malaria

parasite which relishes riding on the invertebrate mosquito vector to fly from one vertebrate victim to another vertebrate host is

not easy to control. Its ancient heritage appears to have taught the parasite to emerge with heightened vengeance whenever we have

challenged it with either ill equipped vaccines or misused drugs. Today’s malaria parasite is well equipped to conquer almost all

anti-malarial drugs through resistance and we have miles to go before we have credible vaccines against malaria. While it is true

that our best drugs against several diseases including Malaria have been gifts of nature, it is equally true that synthetic medicinal

chemistry has played a commendable role in chiseling and tweaking Nature’s pharmacophores to enhance potency, decrease toxicity

and making drugs affordable for the poorest of the poor. My talk will illustrate the ethos of my laboratory which is to study marine

organisms, medicinal plants,

Cyanobacteria

and endophytic fungi for new drugs against Malaria. Towards this mission, we are using

high through put fluorescence based micro-titer plate assays to culture the malaria parasite in human red blood cells and to examine

the effects of potential drugs on the growth of the parasite. On finding hits, we subject natural extracts to activity guided high

resolution chromatographic separation to isolate highly purified compounds against Malaria. Working in close association with

“chemical collaborators” we then determine the chemical structures of Nature’s pharmacophores and validate the same through

chemical synthesis. While the pursuit of discovering novel anti-malarial is continuing, we are currently engaged in fine tuning of a

natural antimalarial for optimum medicinal properties and drug ability.

Biography

Dinkar Sahal’s laboratory epitomizes a vibrant atmosphere for both design and discovery of novel antibiotic peptides and anti-malarial drugs. The foundations for

understanding the mechanisms of action and discovery of the origins of potency, synergy among antibiotics and broad spectrum of action of antibiotic peptides has

been laid in his laboratory. Likewise discovery of novel drugs against drug resistant malaria is a major passion of his laboratory. He has published more than 75

papers in reputed journals and has been serving as a Reviewer and an Editorial Board Member of different journals.

dinkar@icgeb.res.in

Dinkar Sahal, Health Care: Current Reviews 2016, 4:3(Suppl)

http://dx.doi.org/10.4172/2375-4273.C1.023